The DOI matches its Crossref record; the references it cites are not checked yet.
Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue
Abstract
The aim of this study was to define factors predictive of the onset of the terminal phase, defined by hyperbilirubinemia or the occurrence of a severe clinical complication, in patients with primary biliary cirrhosis treated with ursodeoxycholic acid. The 97 primary biliary cirrhosis patients in this study participated in a 2-yr clinical trial. Four of the 49 patients treated with ursodeoxycholic acid (13 to 15 mg/kg/day) entered the terminal phase of the disease, compared with 9 of the 48 patients assigned to placebo. In addition to clinical, conventional biological and histological parameters, we analyzed three serum markers of connective tissue components--type III procollagen aminoterminal peptide, hyaluronic acid and laminin. In the ursodeoxycholic acid-treated group, hyaluronic acid, type III procollagen aminoterminal peptide, bilirubin and splenomegaly were the factors most closely associated with entry into the terminal phase of the disease. In multivariate analysis, after adjustment for age, the hyaluronic acid level was the only predictive factor. In the placebo-treated group, the bilirubin level, total bile acid level, Mayo score, type III procollagen aminoterminal peptide, hyaluronic acid, splenomegaly and pruritus were associated with aggravation of disease. In multivariate analysis, high bilirubin level, high type III procollagen aminoterminal peptide or hyaluronic acid levels and low prothrombin time independently implied poor prognosis. In conclusion, when pat…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyaluronic acid was the first marker to show significant association with clinical outcomes [81,82].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [82]
In the citing paper
“Hyaluronic acid was the first marker to show significant association with clinical outcomes [81,82].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [82]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 31 · Cited by 58
Research works printed but not linked: 5
- Poupon, 1992, Hepatology, 16, 91
- Plebani, 1991, Clin Chem, 24, 219
- Cox, 1972, J R Stat Soc B, 34, 187
- The PHGLM procedure. SUGI Supplemental Library User's Guide, version 5. Cary, NC: SAS Institut. Inc., 1986.
- BMDP statistical software. Los Angeles: University of California Press, 1990.
Metadata
- Authors
- Poupon, R. E., Balkau, B., Guéchot, J., & Heintzmann, F.
- Affiliations
- Inserm (FR)
- ORCID
- Balkau, Beverley
- Venue
- Hepatology
- Published
- 1994-03
- Volume
- 19
- Issue
- 3
- Pages
- 635-640
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2039586762
- Semantic Scholar
- 2a18e1d16b7c1e990cc93dd9232be120f34403c8
- Cited by
- 58
- References
- 31
- Citations by year
- 2025: 1 · 2023: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 3
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 7854 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- primary biliary cirrhosis, ursodeoxycholic acid, hyaluronic acid, laminin, hyperbilirubinemia, splenomegaly, prognosis
- MeSH terms
- Adult, Aged, Connective Tissue, Female, Forecasting, Humans, Hyperbilirubinemia, Liver Cirrhosis, Biliary, Male, Middle Aged, Placebos, Ursodeoxycholic Acid, Biomarkers, Multivariate Analysis, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue. https://app.cochat.ai/papers/10.1002/hep.1840190314
- The paper
- Poupon, R. E., Balkau, B., Guéchot, J., & Heintzmann, F. (1994). Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue. Hepatology. https://doi.org/10.1002/hep.1840190314
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.